ELCC Daily Highlights brings you the latest news and developments in research and practice of lung cancer, as presented during the conference. Conference delegates are invited to click here to complete the Online Evaluation and print out their Certificate of Attendance.
This feature will be available through the ESMO website for 4 weeks after the end of the Conference.
| Issue | Date | Topics |
|---|
Issue No 3
| Friday, 30 April 2010 | - Serum proteomic prediction of outcomes in advanced NSCLC patients treated with erlotinib/placebo in the NCIC Clinical Trials Group BR.21 trial
- Different KRAS mutations may predict a different impact on drug activity in NSCLC
- Analysis of biomarkers in the AVAiL phase III randomized study of first-line bevacizumab with cisplatin-gemcitabine in NSCLC patients
- Stay with us: Overview of the ELCC program for Saturday, 1 May
- Looking for something to do over the weekend?
|
Issue No 2
| Thursday, 29 April 2010 | - CXCR4 over-expression by immunohistochemistry heralds poor outcome in metastatic NSCLC
- Lung volume reduction surgery in patients with lung carcinoma
- Radiological and clinical pneumonitis after stereotactic lung radiotherapy
- Advantages and limitations of different imaging techniques used in chest imaging
- Meet colleagues and exchange news and ideas beyond the program sessions
|
Issue No 1 | Wednesday, 28 April 2010 | - Tobacco control- What is important for oncologists to know?
- Novel therapeutic agents
- Consequences of the new staging system
- Get the most value from your ELCC experience
|
BACK TO TOP
PRINT THIS PAGE